Robbins LLP Reminds Investors of Cardlytics, Inc. (CDLX) of the Pending Lead Plaintiff Deadline and Urges Investors to Obtain Counsel

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Cardlytics, Inc. (NASDAQ: CDLX) securities between March 14, 2024, and August 7, 2024, due to allegations of misleading information regarding the company's business prospects [1][2]. Allegations - The complaint alleges that during the class period, Cardlytics failed to disclose several critical factors: - Increasing consumer engagement led to higher consumer incentives [2] - The company was unable to increase its billings in line with the increased consumer engagement [2] - There was a significant risk that revenue growth would slow or decline as a result [2] - Changes to the Ad Decision Engine, which increased consumer engagement, resulted in "underdelivery" of budgets and customer billing estimates [2] Financial Performance - On August 7, 2024, Cardlytics reported its Q2 2024 financial results, showing a 9% year-over-year revenue decrease to $69.6 million and a 3$36.4 million [3] - Following the announcement, the company's stock price dropped by $3.94, or 57.1$2.96 per share on August 8, 2024 [3] Class Action Participation - Shareholders interested in serving as lead plaintiffs must file necessary documents with the court by March 25, 2025 [4] - Participation in the case is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]